http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2007118240-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-534 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-534 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 |
| filingDate | 2005-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2007118240-A |
| titleOfInvention | MEDICINAL PRODUCT OF SEDATIVE AND SPASMOLITIC ACTION AND METHOD OF ITS PRODUCTION (OPTIONS) |
| abstract | 1. A drug of sedative and antispasmodic action, containing ethyl ester of α-bromisovalerianic acid, phenobarbital and peppermint oil, characterized in that it additionally contains microcrystalline cellulose, auxiliary substances for creating a solid dosage form in the form of tablets in the following ratio of components, wt.%% : wherein the tablets are coated with a β-cyclodextrin or its derivatives. 2. The drug according to claim 1, characterized in that it further comprises β-cyclodextrin in a dose of up to 70 wt.%. 3. The drug according to claim 1, characterized in that it further comprises hop oil in a dose of 0.0229-0.09 wt.%. 4. The drug according to claim 1, characterized in that it further comprises powders with a developed surface of the crystals in a dose of up to 6 wt.%. The medicine according to claim 4, characterized in that aerosil, calcium alginate, pectin and / or mixtures thereof are used as powders with a developed surface. A medicine according to any one of claims 1 to 4, characterized in that fillers, disintegrants, glidants are used as auxiliary substances. The medicine according to claim 6, characterized in that lactose, starch, glycine, calcium diphosphate, calcium dihydrogen phosphate, glucose, sorbitol and / or mixtures thereof are used as fillers. The medicine according to claim 6, characterized in that starch and its derivatives: crospovidone, croscarmellose and / or mixtures thereof are used as disintegrants. The medicine according to claim 6, characterized in that magnesium stearate, sodium fumarate, talc, p |
| priorityDate | 2004-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 65.